Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Grant or award EVP, Research and Development acquired 9,989 shares (grant or award)
  2. 4 Grant or award EVP, HR acquired 4,495 shares (grant or award)
  3. 4 Grant or award VP, Finance & CAO acquired 436 shares (grant or award)
  4. 4 Grant or award SVP, Business Development acquired 923 shares (grant or award)
  5. 4 Grant or award SVP & CCO acquired 1,001 shares (grant or award)
  6. 4 Grant or award EVP, Gen. Counsel & Secy. acquired 6,992 shares (grant or award)
  7. 4 Grant or award EVP Global Commercial Ops acquired 9,989 shares (grant or award)
  8. 4 Grant or award Chairman, CEO and President acquired 34,964 shares (grant or award)
  9. 4 Insider Changes in Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 152.03 shares (grant or award)
  12. 4 Grant or award Director acquired 187.12 shares (grant or award)
  13. 4 Grant or award VP, Finance & CAO acquired 350 shares (grant or award)
  14. 4 Grant or award SVP, Business Development acquired 2,104 shares (grant or award)
  15. 4 Grant or award SVP & CCO acquired 935 shares (grant or award)
  16. 4 Shares withheld for taxes EVP, Research and Development gave up 2,192 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP Global Commercial Ops gave up 5,585 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP, HR gave up 1,352 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP & CFO gave up 2,661 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Gen. Counsel & Secy. gave up 1,591 shares (to pay taxes)

Page 22 of 99 · 1,961 filings